Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-30 Sale | 2022-12-02 5:48 pm | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 23,131 | $46.94 | $1,085,739 | 284,364 (Indirect Direct) | View |
| 2022-10-28 Sale | 2022-11-01 5:38 pm | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 44,103 | $40.31 | $1,777,829 | 307,495 (Indirect Direct) | View |
| 2022-10-25 Sale | 2022-10-27 9:50 pm | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 285,487 | $42.71 | $12,193,196 | 351,598 (Indirect Direct) | View |
| 2020-11-24 Purchase | 2020-11-25 5:03 pm | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 375,000 | $39 | $14,625,000 | 17,161,713 (Indirect) | View |
| 2020-07-10 Purchase | 2020-07-14 4:45 pm | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director 10% Owner | 415,000 | $36 | $14,940,000 | 5,830,203 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-08 Option Award | 2024-06-11 5:22 pm | N/A 2034-06-07 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:32 pm | N/A 2034-06-04 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director | 7,639 | $0 | 7,639 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:48 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:23 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:00 pm | N/A 2032-06-06 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:25 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 4:57 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:56 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:26 pm | N/A 2030-06-02 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 14,777 | $0 | 14,777 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 6:52 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director 10% Owner | 13,000 | $0 | 13,000 (Direct) | View |